Burosumab for Tumor-Induced Osteomalacia: Not Enough of a Good Thing

被引:6
|
作者
Hartley, Iris R. [1 ]
Collins, Michael T. [1 ]
机构
[1] Natl Inst Dent & Craniofacial Res, Natl Inst Hlth, Bethesda, MD USA
关键词
D O I
10.1002/jbmr.4318
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2453 / 2454
页数:2
相关论文
共 50 条
  • [1] Reply to: Burosumab for Tumor-Induced Osteomalacia: not Enough of a Good Thing
    Jan de Beur, Suzanne M.
    Miller, Paul D.
    Weber, Thomas J.
    Peacock, Munro
    Insogna, Karl
    Kumar, Rajiv
    Rauch, Frank
    Luca, Diana
    Cimms, Tricia
    Roberts, Mary Scott
    Martin, Javier San
    Carpenter, Thomas O.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2021, 36 (12) : 2455 - 2456
  • [2] Burosumab for the Treatment of Tumor-Induced Osteomalacia
    Jan de Beur, Suzanne M.
    Miller, Paul D.
    Weber, Thomas J.
    Peacock, Munro
    Insogna, Karl
    Kumar, Rajiv
    Rauch, Frank
    Luca, Diana
    Cimms, Tricia
    Roberts, Mary Scott
    San Martin, Javier
    Carpenter, Thomas O.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2021, 36 (04) : 627 - 635
  • [3] Appropriate dosing of burosumab in tumor-induced osteomalacia
    Colangelo, Luciano
    Sonato, Chiara
    Riminucci, Mara
    Corsi, Alessandro
    Minisola, Salvatore
    OSTEOPOROSIS INTERNATIONAL, 2022, 34 (2) : 421 - 421
  • [4] Burosumab in Tumor-Induced Osteomalacia: A Case Report
    Carvalho, Erico
    Moraes, Juliana
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 127 - 128
  • [5] Burosumab in tumor-induced osteomalacia: A case report
    Paccou, Julien
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 215 - 216
  • [6] Burosumab in tumor-induced osteomalacia: A case report
    Day, Alvin Lee
    Gutierrez, Orlando M.
    Guthrie, Barton L.
    Saag, Kenneth G.
    JOINT BONE SPINE, 2020, 87 (01) : 81 - 83
  • [7] Appropriate dosing of burosumab in tumor-induced osteomalacia
    Luciano Colangelo
    Chiara Sonato
    Mara Riminucci
    Alessandro Corsi
    Salvatore Minisola
    Osteoporosis International, 2023, 34 : 421 - 421
  • [8] Reply to: appropriate dosing of burosumab in tumor-induced osteomalacia
    Crotti, C.
    Zucchi, F.
    Alfieri, C.
    Caporali, R.
    Varenna, M.
    OSTEOPOROSIS INTERNATIONAL, 2022, 34 (2) : 423 - 424
  • [9] Reply to: appropriate dosing of burosumab in tumor-induced osteomalacia
    C. Crotti
    F. Zucchi
    C. Alfieri
    R. Caporali
    M. Varenna
    Osteoporosis International, 2023, 34 : 423 - 424
  • [10] Long-term use of burosumab for the treatment of tumor-induced osteomalacia
    Crotti, C.
    Zucchi, F.
    Alfieri, C.
    Caporali, R.
    Varenna, M.
    OSTEOPOROSIS INTERNATIONAL, 2023, 34 (01) : 201 - 206